Clinical Trial Update: Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy, safety, and tolerability of multiple doses of valsartan in children with hypertension with or without chronic kidney disease (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Pediatric Hypertension With or Without CKD | Phase 3 | Status: COMPLETED | Results posted: 2017-09-27